Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacturing, and sale of surgical medical devices, staplers, and spar...
Pre-market hot trades in US stocks: Planet Green fell 3.89% in pre-market; IREN rose 3.82% in pre-market
The mainland medical device stock "Tianxing Medical" has submitted an application for listing again
Canopus: Net loss of 83.4945 million yuan in the third quarter
Canopus plans to acquire 90% equity of Wuhan Yijiaobao, which is expected to constitute a major asset reorganization
Canopus: Net profit of 30.2929 million yuan in the first half of 2025, a year-on-year decrease of 36.47%
Canopus's subsidiary Dongxing Biotechnology signed a technology development (entrustment) contract with Shanghai Jiao Tong University